Chemoradiotherapy in Patients With Localised Lung Cancer

NCT00193921 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG: Vinorelbine
RADIATION: High dose Radiotherapy
DRUG: Gemcitabine
DRUG: Cisplatin
RADIATION: High Dose Radiotherapy

Sponsor

Trans Tasman Radiation Oncology Group

Collaborators

[object Object]
[object Object]